Cargando…
Molecular signature induced by RNASET2, a tumor antagonizing gene, in ovarian cancer cells
Using the Hey3Met2 human ovarian cancer cell line, we previously found the RNASET2 gene to possess a remarkable in vivo tumor suppressor activity, although no in vitro features such as inhibition of cell proliferation, clonogenic potential, impaired growth in soft agar and increase in apoptotic rate...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248199/ https://www.ncbi.nlm.nih.gov/pubmed/21646684 |
_version_ | 1782220214101868544 |
---|---|
author | Acquati, Francesco Monti, Laura Lualdi, Marta Fabbri, Marco Sacco, Maria Grazia Gribaldo, Laura Taramelli, Roberto |
author_facet | Acquati, Francesco Monti, Laura Lualdi, Marta Fabbri, Marco Sacco, Maria Grazia Gribaldo, Laura Taramelli, Roberto |
author_sort | Acquati, Francesco |
collection | PubMed |
description | Using the Hey3Met2 human ovarian cancer cell line, we previously found the RNASET2 gene to possess a remarkable in vivo tumor suppressor activity, although no in vitro features such as inhibition of cell proliferation, clonogenic potential, impaired growth in soft agar and increase in apoptotic rate could be detected. This is reminiscent of the behavior of genes belonging to the class of tumor antagonizing genes (TAG) which act mainly within the context of the microenvironment. Here we present transcriptional profiles analysis which indicates that investigations of the mechanisms of TAG biological functions require a comparison between the in vitro and in vivo expression patterns. Indeed several genes displaying a biological function potentially related to tumor suppression could not be validated by subsequent in vivo expression analysis. On the other hand the fact that we could find congruency for three genes both in vivo and in vitro adds a warning to a too much stringent categorization of this class of genes which relies on the sensitivity of the methodological approaches. |
format | Online Article Text |
id | pubmed-3248199 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-32481992012-01-18 Molecular signature induced by RNASET2, a tumor antagonizing gene, in ovarian cancer cells Acquati, Francesco Monti, Laura Lualdi, Marta Fabbri, Marco Sacco, Maria Grazia Gribaldo, Laura Taramelli, Roberto Oncotarget Research Perspectives Using the Hey3Met2 human ovarian cancer cell line, we previously found the RNASET2 gene to possess a remarkable in vivo tumor suppressor activity, although no in vitro features such as inhibition of cell proliferation, clonogenic potential, impaired growth in soft agar and increase in apoptotic rate could be detected. This is reminiscent of the behavior of genes belonging to the class of tumor antagonizing genes (TAG) which act mainly within the context of the microenvironment. Here we present transcriptional profiles analysis which indicates that investigations of the mechanisms of TAG biological functions require a comparison between the in vitro and in vivo expression patterns. Indeed several genes displaying a biological function potentially related to tumor suppression could not be validated by subsequent in vivo expression analysis. On the other hand the fact that we could find congruency for three genes both in vivo and in vitro adds a warning to a too much stringent categorization of this class of genes which relies on the sensitivity of the methodological approaches. Impact Journals LLC 2011-06-04 /pmc/articles/PMC3248199/ /pubmed/21646684 Text en Copyright: © 2011 Acquati et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited |
spellingShingle | Research Perspectives Acquati, Francesco Monti, Laura Lualdi, Marta Fabbri, Marco Sacco, Maria Grazia Gribaldo, Laura Taramelli, Roberto Molecular signature induced by RNASET2, a tumor antagonizing gene, in ovarian cancer cells |
title | Molecular signature induced by RNASET2, a tumor antagonizing gene, in ovarian cancer cells |
title_full | Molecular signature induced by RNASET2, a tumor antagonizing gene, in ovarian cancer cells |
title_fullStr | Molecular signature induced by RNASET2, a tumor antagonizing gene, in ovarian cancer cells |
title_full_unstemmed | Molecular signature induced by RNASET2, a tumor antagonizing gene, in ovarian cancer cells |
title_short | Molecular signature induced by RNASET2, a tumor antagonizing gene, in ovarian cancer cells |
title_sort | molecular signature induced by rnaset2, a tumor antagonizing gene, in ovarian cancer cells |
topic | Research Perspectives |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248199/ https://www.ncbi.nlm.nih.gov/pubmed/21646684 |
work_keys_str_mv | AT acquatifrancesco molecularsignatureinducedbyrnaset2atumorantagonizinggeneinovariancancercells AT montilaura molecularsignatureinducedbyrnaset2atumorantagonizinggeneinovariancancercells AT lualdimarta molecularsignatureinducedbyrnaset2atumorantagonizinggeneinovariancancercells AT fabbrimarco molecularsignatureinducedbyrnaset2atumorantagonizinggeneinovariancancercells AT saccomariagrazia molecularsignatureinducedbyrnaset2atumorantagonizinggeneinovariancancercells AT gribaldolaura molecularsignatureinducedbyrnaset2atumorantagonizinggeneinovariancancercells AT taramelliroberto molecularsignatureinducedbyrnaset2atumorantagonizinggeneinovariancancercells |